Azerbaijan vs Moldova: Incidence of tuberculosis (per 100,000 people)
Incidence of tuberculosis (per 100,000 people) over time
- Azerbaijan
- Moldova
How they compare
Azerbaijan currently reports 64 per 100,000 people against 64 per 100,000 people in Moldova, a difference of 0 per 100,000 people.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Azerbaijan ahead.
Azerbaijan ranks 78th and Moldova ranks 78th of 208 countries.
Across the 3 decades both report, Azerbaijan averaged higher in 2 and Moldova in 1.
Head to head by decade
| Decade | Azerbaijan | Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 198.1 per 100,000 people | 110.2 per 100,000 people | 87.9 per 100,000 people | Azerbaijan |
| 2010s | 116.1 per 100,000 people | 113.5 per 100,000 people | 2.6 per 100,000 people | Azerbaijan |
| 2020s | 66.6 per 100,000 people | 75 per 100,000 people | 8.4 per 100,000 people | Moldova |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher incidence of tuberculosis, Azerbaijan or Moldova?
- Azerbaijan, at 64 per 100,000 people against 64 per 100,000 people in Moldova as of 2024.
- What is the difference in incidence of tuberculosis between Azerbaijan and Moldova?
- 0 per 100,000 people, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Moldova?
- 25 years are reported by both, from 2000 to 2024.
- How do Azerbaijan and Moldova rank globally for incidence of tuberculosis?
- Azerbaijan ranks 78th and Moldova ranks 78th of 208 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Incidence of tuberculosis (per 100,000 people). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Incidence of tuberculosis is the estimated number of new and relapse tuberculosis cases arising in a given year, expressed as the rate per 100,000 population. All forms of TB are included, including cases in people living with HIV. Estimates for all years are recalculated as new information becomes available and techniques are refined, so they may differ from those published previously.